Difficulty: Medium
Average Score: 73%
Practice
Human Normal Immunoglobulin (HNIG):
Correct answer
A
Rationale
The correct answer is A) When being used as post-exposure prophylaxis for Hepatitis A may protect against disease if given within 14 days of exposure.
Explanation:
Human Normal Immunoglobulin (HNIG) is used for post-exposure prophylaxis for Hepatitis A. When administered within 14 days of exposure, it can provide passive immunity by neutralizing the virus, thereby protecting against disease development.
Why the other options are incorrect:
B) Live vaccines should preferably not be given for 3 months after administration of HNIG. This is incorrect because HNIG does not interfere with live vaccines, except for the yellow fever vaccine.
C) HNIG does not provide protection lasting up to 2-3 years. It offers temporary passive immunity and protection for a limited duration.
D) HNIG does not contain egg proteins, so it is safe for individuals with egg allergies. This option is incorrect as there is no direct contraindication for HNIG in individuals with egg allergies.
Educational context:
Understanding the appropriate use of Human Normal Immunoglobulin is crucial in infection control practices. Healthcare professionals need to be aware of the indications, contraindications, and timing of administration to ensure effective post-exposure prophylaxis for infectious diseases like Hepatitis A. This knowledge is essential for providing safe and evidence-based care to patients.
Explanation:
Human Normal Immunoglobulin (HNIG) is used for post-exposure prophylaxis for Hepatitis A. When administered within 14 days of exposure, it can provide passive immunity by neutralizing the virus, thereby protecting against disease development.
Why the other options are incorrect:
B) Live vaccines should preferably not be given for 3 months after administration of HNIG. This is incorrect because HNIG does not interfere with live vaccines, except for the yellow fever vaccine.
C) HNIG does not provide protection lasting up to 2-3 years. It offers temporary passive immunity and protection for a limited duration.
D) HNIG does not contain egg proteins, so it is safe for individuals with egg allergies. This option is incorrect as there is no direct contraindication for HNIG in individuals with egg allergies.
Educational context:
Understanding the appropriate use of Human Normal Immunoglobulin is crucial in infection control practices. Healthcare professionals need to be aware of the indications, contraindications, and timing of administration to ensure effective post-exposure prophylaxis for infectious diseases like Hepatitis A. This knowledge is essential for providing safe and evidence-based care to patients.